Fierce Pharma Fierce Biotech Fierce Healthcare Fierce Life Sciences Events Advertise About Us Biotech Cell & Gene Therapy Clinical Data Venture Capital Deals Research Medtech Devices Diagnostics AI and Machine Learning CRO Special Reports Trending Biologics Clinical Development Ophthalmology Cell & Gene Therapy Fierce 50 Special Report Awards Gala Awards CRO Awards Innovation Awards Resources Fierce Events Industry Events Webinars Podcasts Whitepapers Survey Events Subscribe Trending Biotech Cell & Gene Therapy Clinical Data Venture Capital Deals Research Medtech Devices Diagnostics AI and Machine Learning CRO Special Reports Trending Biologics Clinical Development Ophthalmology Cell & Gene Therapy Fierce 50 Special Report Awards Gala Awards CRO Awards Innovation Awards Resources Fierce Events Industry Events Webinars Podcasts Whitepapers Survey Events Subscribe Fierce Pharma Fierce Biotech Fierce Healthcare Fierce Life Sciences Events Advertise About Us Sponsored Biotech Dana-Farber oncologist Anthony Letai tapped to direct National Cancer Institute By Real Chemistry Sep 30, 2025 5:50am Chutes and Ladders National Cancer Institute National Institutes of Health (NIH) Department of Health and Human Services (HHS) The editorial staff had no role in this post's creation. Chutes and Ladders National Cancer Institute National Institutes of Health (NIH) Department of Health and Human Services (HHS) Oncology Dana-Farber Cancer Institute Harvard Medical School Research Biotech
